New PARTNER trial sub-study data show that post-operative ctDNA detection using tumour-informed MRD assays can accurately predict distant recurrence risk in triple-negative breast cancer patients
The hospital successfully treats two complex high-risk cardiac patients using advanced minimally invasive heart surgeries
The filing is backed by Phase III data from the lidERA Breast Cancer study
The companies say the drug has now demonstrated clinical benefit in three separate Phase 3 trials
The facility sets a new benchmark in respiratory diagnostics
Acquisition provides direct access to the Dutch healthcare market, enhancing Marksans’ sales, distribution and market-access capabilities across regulated European markets
The safety profile was described as manageable, though not without notable toxicities
Fertility platform launches flagship clinic with advanced IVF tech
Approved as a web-based pre-diagnostic tool for suspected rare diseases and classified as a Class A (non-sterile and non-measuring) medical device
This marks one of the most closely watched oncology readouts at this year’s medical congress
Subscribe To Our Newsletter & Stay Updated
